RT Journal Article
SR Electronic
T1 820 ANV600 is a novel PD-1 targeted IL-2Rβ/γ agonist that is combinable with therapeutic PD-1 inhibitors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A918
OP A918
DO 10.1136/jitc-2023-SITC2023.0820
VO 11
IS Suppl 1
A1 Murer, Patrizia
A1 Salazar, Ulisse
A1 Egli, Nicole
A1 Petersen, Laetitia
A1 Neubert, Pia
A1 Stocker, Christian
A1 Rau, Alexander
A1 Richter, Kirsten
A1 Katopodis, Andreas
A1 Huber, Christoph
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A918.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.